NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Antidote Technologies

Antidote Technologies

Private
Miami, FloridaHealthcare & Life Scienceshttps://www.antidote.me/

Last Round

Series C

Jun 3, 2021

Total Funding Raised

$41M

Company Overview

Antidote Technologies is a digital health company that provides a patient recruitment and matching platform to connect individuals with clinical trials.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Patient Engagement, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

clinical trial recruitmentpatient recruitmentclinical trial matchingpatient engagementpatient enrollmentclinical trial softwarecontract research organizationCROAPI integrationhealthcare analyticspatient matchingclinical trial feasibilitydigital healthpatient matching softwaretrial matching

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Antidote Technologies Comparables

Compare Antidote Technologies with similar companies based on industry and business-model similarity.

Antidote Technologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Patiro
86%
AutoCruitment
86%
Carebox Healthcare Solutions
86%

Antidote Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJun 3, 2021
VC RoundSep 7, 2017
Series BFeb 5, 2015
Series AMay 8, 2013
SeedOct 27, 2011

Antidote Technologies Investors

Notable investors and investment history

Antidote Technologies investors
InvestorRounds
Amadeus Capital PartnersSeries B, Series A, Seed
Smedvig CapitalSeries C, VC Round, Series B
LBO FranceSeries C
Octopus InvestmentsSeries B, Series A
Octopus VenturesSeries C, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 7, 2017

    $11M round led by Merck & Co., Inc.

Antidote Technologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Antidote Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Antidote Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersMiami, Florida
Employee Range23
Year Founded2010
Last FundingJun 3, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.